Varenicline efficacy and tolerability in a subject with schizophrenia.
Fatemi
S Hossein
SH
D000328:Adult; D001552:Benzazepines / Q000627:therapeutic use*; D010054:Brief Psychiatric Rating Scale; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D018722:Nicotinic Agonists / Q000627:therapeutic use*; D011810:Quinoxalines / Q000627:therapeutic use*; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D016540:Smoking Cessation; D000068580:Varenicline
D001552:Benzazepines; D018722:Nicotinic Agonists; D011810:Quinoxalines; D000068580:Varenicline